The hereditary N363K POLE exonuclease mutant extends PPAP tumor spectrum to glioblastomas by causing DNA damage and aneuploidy in addition to increased mismatch mutagenicity.
Saved in:
| Title: | The hereditary N363K POLE exonuclease mutant extends PPAP tumor spectrum to glioblastomas by causing DNA damage and aneuploidy in addition to increased mismatch mutagenicity. |
|---|---|
| Authors: | Labrousse G; Cancer Research Center of Toulouse, CRCT, 2 Avenue Hubert Curien, 31000Toulouse, France., Vande Perre P; Cancer Research Center of Toulouse, CRCT, 2 Avenue Hubert Curien, 31000Toulouse, France.; Oncogenetics Department, Institute Claudius Regaud, IUCT-Oncopole, Toulouse, France., Parra G; Center for Genomic Analysis, CNAG, Carrer de Baldiri Reixac 4, Barcelona, Spain., Jaffrelot M; Cancer Research Center of Toulouse, CRCT, 2 Avenue Hubert Curien, 31000Toulouse, France.; Oncogenetics Department, Institute Claudius Regaud, IUCT-Oncopole, Toulouse, France.; Department of Digestive Oncology, IUCT Rangueil-Larrey, CHU de Toulouse, Toulouse, France., Leroy L; Cancer Research Center of Toulouse, CRCT, 2 Avenue Hubert Curien, 31000Toulouse, France., Chibon F; Cancer Research Center of Toulouse, CRCT, 2 Avenue Hubert Curien, 31000Toulouse, France., Escudie F; Laboratoire d'Excellence Toulouse Cancer (TOUCAN), Laboratoire de Pathologie, Institut Universitaire du Cancer-Toulouse, Oncopole, 1 Avenue Irene-Joliot-Curie, 31059Toulouse, France., Selves J; Cancer Research Center of Toulouse, CRCT, 2 Avenue Hubert Curien, 31000Toulouse, France.; Laboratoire d'Excellence Toulouse Cancer (TOUCAN), Laboratoire de Pathologie, Institut Universitaire du Cancer-Toulouse, Oncopole, 1 Avenue Irene-Joliot-Curie, 31059Toulouse, France., Hoffmann JS; Cancer Research Center of Toulouse, CRCT, 2 Avenue Hubert Curien, 31000Toulouse, France.; Laboratoire d'Excellence Toulouse Cancer (TOUCAN), Laboratoire de Pathologie, Institut Universitaire du Cancer-Toulouse, Oncopole, 1 Avenue Irene-Joliot-Curie, 31059Toulouse, France., Guimbaud R; Oncogenetics Department, Institute Claudius Regaud, IUCT-Oncopole, Toulouse, France.; Department of Digestive Oncology, IUCT Rangueil-Larrey, CHU de Toulouse, Toulouse, France., Lutzmann M; Cancer Research Center of Toulouse, CRCT, 2 Avenue Hubert Curien, 31000Toulouse, France.; Institute of Human Genetics, IGH, UMR 9002, Centre National de la Recherche Scientifique, University of Montpellier, 34396Montpellier, France. |
| Source: | NAR cancer [NAR Cancer] 2023 Mar 11; Vol. 5 (2), pp. zcad011. Date of Electronic Publication: 2023 Mar 11 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101769553 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-8674 (Electronic) Linking ISSN: 26328674 NLM ISO Abbreviation: NAR Cancer Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36915289 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The hereditary N363K POLE exonuclease mutant extends PPAP tumor spectrum to glioblastomas by causing DNA damage and aneuploidy in addition to increased mismatch mutagenicity. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Labrousse+G%22">Labrousse G</searchLink>; Cancer Research Center of Toulouse, CRCT, 2 Avenue Hubert Curien, 31000Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Vande+Perre+P%22">Vande Perre P</searchLink>; Cancer Research Center of Toulouse, CRCT, 2 Avenue Hubert Curien, 31000Toulouse, France.; Oncogenetics Department, Institute Claudius Regaud, IUCT-Oncopole, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Parra+G%22">Parra G</searchLink>; Center for Genomic Analysis, CNAG, Carrer de Baldiri Reixac 4, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Jaffrelot+M%22">Jaffrelot M</searchLink>; Cancer Research Center of Toulouse, CRCT, 2 Avenue Hubert Curien, 31000Toulouse, France.; Oncogenetics Department, Institute Claudius Regaud, IUCT-Oncopole, Toulouse, France.; Department of Digestive Oncology, IUCT Rangueil-Larrey, CHU de Toulouse, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Leroy+L%22">Leroy L</searchLink>; Cancer Research Center of Toulouse, CRCT, 2 Avenue Hubert Curien, 31000Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Chibon+F%22">Chibon F</searchLink>; Cancer Research Center of Toulouse, CRCT, 2 Avenue Hubert Curien, 31000Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Escudie+F%22">Escudie F</searchLink>; Laboratoire d'Excellence Toulouse Cancer (TOUCAN), Laboratoire de Pathologie, Institut Universitaire du Cancer-Toulouse, Oncopole, 1 Avenue Irene-Joliot-Curie, 31059Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Selves+J%22">Selves J</searchLink>; Cancer Research Center of Toulouse, CRCT, 2 Avenue Hubert Curien, 31000Toulouse, France.; Laboratoire d'Excellence Toulouse Cancer (TOUCAN), Laboratoire de Pathologie, Institut Universitaire du Cancer-Toulouse, Oncopole, 1 Avenue Irene-Joliot-Curie, 31059Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Hoffmann+JS%22">Hoffmann JS</searchLink>; Cancer Research Center of Toulouse, CRCT, 2 Avenue Hubert Curien, 31000Toulouse, France.; Laboratoire d'Excellence Toulouse Cancer (TOUCAN), Laboratoire de Pathologie, Institut Universitaire du Cancer-Toulouse, Oncopole, 1 Avenue Irene-Joliot-Curie, 31059Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Guimbaud+R%22">Guimbaud R</searchLink>; Oncogenetics Department, Institute Claudius Regaud, IUCT-Oncopole, Toulouse, France.; Department of Digestive Oncology, IUCT Rangueil-Larrey, CHU de Toulouse, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Lutzmann+M%22">Lutzmann M</searchLink>; Cancer Research Center of Toulouse, CRCT, 2 Avenue Hubert Curien, 31000Toulouse, France.; Institute of Human Genetics, IGH, UMR 9002, Centre National de la Recherche Scientifique, University of Montpellier, 34396Montpellier, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101769553%22">NAR cancer</searchLink> [NAR Cancer] 2023 Mar 11; Vol. 5 (2), pp. zcad011. <i>Date of Electronic Publication: </i>2023 Mar 11 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101769553 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2632-8674 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226328674%22">26328674 </searchLink><i>NLM ISO Abbreviation: </i>NAR Cancer <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36915289 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/narcan/zcad011 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: zcad011 Titles: – TitleFull: The hereditary N363K POLE exonuclease mutant extends PPAP tumor spectrum to glioblastomas by causing DNA damage and aneuploidy in addition to increased mismatch mutagenicity. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Labrousse G – PersonEntity: Name: NameFull: Vande Perre P – PersonEntity: Name: NameFull: Parra G – PersonEntity: Name: NameFull: Jaffrelot M – PersonEntity: Name: NameFull: Leroy L – PersonEntity: Name: NameFull: Chibon F – PersonEntity: Name: NameFull: Escudie F – PersonEntity: Name: NameFull: Selves J – PersonEntity: Name: NameFull: Hoffmann JS – PersonEntity: Name: NameFull: Guimbaud R – PersonEntity: Name: NameFull: Lutzmann M IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 03 Text: 2023 Mar 11 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2632-8674 Numbering: – Type: volume Value: 5 – Type: issue Value: 2 Titles: – TitleFull: NAR cancer Type: main |
| ResultId | 1 |
